Hungary - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Hungary Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry was down by 0.3% year on year. With $426,636,826.27 Million PPP in 2019, the country was ranked number 16 comparing other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry. Hungary is overtaken by Austria, which was ranked number 15 at $427,223,717.42 Million PPP and is followed by Canada at $420,159,373.17 Million PPP. United States lead the ranking with $70,565,318,932.39 Million PPP in 2019, an increase of 3.3% versus 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +43.9% per year, while Lithuania recorded the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 426,636,826.27 |
| 2018 | 419,444,493.52 |
| 2017 | 405,120,877.40 |
| 2016 | 414,423,227.24 |
| 2015 | 406,872,414.88 |
How does Hungary rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 15 |
#15
Austria
|
427,223,717.42 | 2019 | +3.0 % | +2.4 % | View data | |
| 16 |
#16
Hungary
|
426,636,826.27 | 2019 | +1.7 % | -0.3 % | View data | |
| 17 |
#17
Canada
|
420,159,373.17 | 2019 | -1.6 % | +2.3 % | View data | |